Authors
- Şadiye A. Tuzcu, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
- Ilbey E. Çetin, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
- Erdal Çetinkaya, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
- Fatih Güzel, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
- Dilek Geneş, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
- İbrahim İbiloğlu, From the Department of Nuclear Medicine (Tuzcu, Çetin, Çetinkaya), Department of Endocrinology and Metabolism (Geneş), and from the Department of Pathology (İbiloğlu), Dicle University Medical Faculty, and from Department of Nuclear Medicine (Güzel), Gaziyaşargil Training and Research Hospital, Diyarbakır, Turkey.
Abstract
ABSTRACT Objectives: To compare the SUV max –SUV mean values of the thyroid gland nodules and the SUV max –SUV mean ratios of the nodules to normal thyroid gland with the fine-needle aspiration biopsy (FNAB) results, to determine the importance of nodule SUV max value in the detection of malignancy. Methods: This study included 788 patients without a diagnosis of thyroid cancer who exhibited focal uptake in the thyroid gland on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT. Of these, 131 patients underwent FNAB. SUV max –SUV mean values of the nodules and normal thyroid tissue were measured on PET/CT imaging, along with the pathology reports of the patients who underwent FNAB. Results: Patients with malignant tumors, nodules exhibited higher SUV max and SUV mean values for both nodules and nodules/normal thyroid tissue ratio compared to those with benign group. The thyroid SUV max and SUV mean values were higher in the benign group. The area under the curve for the nodule SUV max was 84.6%, and the cut-off value was determined to be 5.5, with a discrimination ability of 80%–90%. Conclusion: The area under the curve for the nodule SUV max showed the statistical significance of the diagnostic discrimination ability of the test. The findings suggest that nodule SUV max provides good discrimination ability for malignancy detection, indicating its potential utility as a diagnostic marker.
Article Type
Research Article
Recommended Citation
Tuzcu, Şadiye A.; Çetin, Ilbey E.; Çetinkaya, Erdal; Güzel, Fatih; Geneş, Dilek; and İbiloğlu, İbrahim
(2025)
"Comparison of incidentally detected focal FDG uptake in the thyroid gland on PET/CT with fine needle aspiration biopsy results,"
Saudi Medical Journal: Vol. 46:
Iss.
8, Article 8.
DOI: https://doi.org/10.15537/smj.2025.46.8.20241077
DOWNLOADS
Since April 09, 2026
COinS